Purchase Order 75F40123P00344

The Food and Drug Administration awarded a $65,523 firm fixed-price purchase order to Agilent Technologies Inc. on June 29, 2021, for software update and qualification services related to OpenLab Chromatography Data System (CDS) and Electronic Compliance Management (ECM) software. The contract is scheduled for completion by July 5, 2022, with performance at the FDA's Silver Spring, Maryland facility. This award was made without set-aside designation, indicating full and open competition. Agilent...

The Food and Drug Administration awarded a $188,012.26 delivery order to Agilent Technologies Inc. for maintenance and support services related to OpenLab CDS (Chromatography Data System) and ECM (Enterprise Content Management) software. The contract, issued on September 10, 2025, with an ultimate completion date of September 10, 2026, represents a firm fixed-price engagement under a Multiple Award Schedule vehicle. The work will be performed in Brinklow, Maryland, supporting FDA's laboratory...

<p>The Food and Drug Administration awarded a purchase order to Agilent Technologies Inc. for $189,748.80 to exercise Option 3 extending the OpenLab ECM Scientific Data Management System Maintenance Agreement period of performance from September 26, 2026 through September 25, 2027, with award date September 14, 2023.</p> <p>Work is performed in Cincinnati, Ohio. This is a firm fixed price purchase order with no set-aside designation. The ultimate completion date is September 25, 2028.</p>

The Food and Drug Administration awarded a $18,089.86 firm fixed-price purchase order to Agilent Technologies, Inc. (Santa Clara Site division) on March 15, 2023, for an Agilent software upgrade. The contract was awarded without a set-aside designation through full and open competition and is scheduled for ultimate completion on March 19, 2024. The place of performance is located in Calverton, Maryland. As a leading provider of analytical instruments and laboratory solutions, Agilent...

The Food and Drug Administration awarded a $22,964.38 firm fixed-price delivery order to Agilent Technologies Inc. on July 24, 2024, for an Agilent workstation and software upgrade to be completed by September 25, 2025. The contract, which carries no set-aside designation, is being performed at a location in Marshtonville, Delaware, and represents a task order under Agilent's Multiple Award Schedule contract vehicle with the federal government. This delivery order falls within Agilent's...

<p>The Food and Drug Administration awarded a purchase order to Agilent Technologies Inc. on September 28, 2022, for services to move one Agilent 6550 LC-MS system composed of five system modules, with a ceiling value of $33,112.77. Performance takes place in Marshallton, Delaware. The order carries no set-aside designation. Ultimate completion is December 28, 2023. The purchase order originated from a solicitation posted September 22, 2022, with a due date of September 26, 2022.</p>

This is a firm fixed-price purchase order for $23,783.08 awarded by the Food and Drug Administration (FDA) to Agilent Technologies Inc., Customer Service and Sales Division, a subsidiary of the parent company Agilent Technologies, Inc. The contract is for the upgrade of an OpenLab LC ChemStation system, with a completion date of September 22, 2024. Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets, providing a wide range of analytical...

<p>The Food and Drug Administration issued a $14,645.84 delivery order to Agilent Technologies, Inc. on August 4, 2010, for Agilent Mass Profiler Pro software.</p> <p>Place of performance is Denver, CO. The order was firm fixed price with an ultimate completion date of August 13, 2010.</p>

The Food and Drug Administration awarded a delivery order valued at $22,385.16 to Agilent Technologies Inc. for preventive maintenance and repair services on an Agilent 1200 High-Performance Liquid Chromatography (HPLC) System, model LC-61254, located in Silver Spring, Maryland. This firm fixed-price delivery order, awarded on August 9, 2022, represents work to be completed by August 21, 2026, and was issued without a set-aside designation, indicating full and open competition. The contract is a...

The Food and Drug Administration awarded a $207,896.24 delivery order to Agilent Technologies Inc. on July 23, 2018, for the upgrade of an Ultra High Performance Liquid Chromatography (UHPLC) system to a Single Quadrupole Liquid Chromatography-Mass Spectrometry (LC-MS) system. This delivery order, with an ultimate completion date of September 10, 2018, was issued under a firm fixed-price contract structure with no set-aside designation. The work was performed at the FDA's facility in...